Pharmaceuticals

Global Generic Drugs Market 2016-2020

  • TEC590208
  • 111 Pages
  • May 2016
  • Pharmaceuticals
About the Generic Drugs Market

Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness. Manufacturers need to apply for an Abbreviated New Drug Application (ANDA) approval to receive approval of generics.

Technavios analysts forecast the global generic drugs market to grow at a CAGR of 10.53% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global generic drugs market for 2016-2020. To calculate the market size, it considers revenue generated from the sales of simple generics, super generics, and biosimilars.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Generic Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Teva Pharmaceuticals
Sandoz
Allergan
Mylan
Sun Pharmaceuticals
STADA Arzneimittel

Other prominent vendors
Abbott
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
Berlin-Chemie
Biocon
Biogen
Boehringer Ingelheim
Celltrion
Cipla
Coherus Biosciences
Dr. Reddy's Laboratory
Daiichi Sankyo
Eli Lilly
Emcure Pharmaceuticals
Eurofarma Laboratories
Gedeon Richter
Gilead Sciences
GlaxoSmithKline
Hospira
Impax
InnoPharma
Intas Pharmaceuticals
Jannsen
Lupin
Merck
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
Natco Pharma
Nexus Pharmaceuticals
Novo Nordisk
Orchid Chemicals & Pharmaceuticals
Parenteral Drugs India
Par Pharmaceutical
Pfizer
Piramal (Abbott Laboratories)
Roche Holdings
Sanofi
Synthon
Towa
Valeant Pharmaceuticals
Zentiva
Zhejiang Chira Medicine Chemicals
Zhejiang Hisun Pharmaceutical
Zydus Cadila Healthcare

Market driver
Patent expiry of top-selling drugs
For a full, detailed list, view our report

Market challenge
Threat of counterfeit drugs
For a full, detailed list, view our report

Market trend
Outsourcing of drug development activities
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>